Pfenex Inc (PFNX) Gross Profit Margin starting from the second quarter 2020 to second quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Pfenex Inc   (NYSEAMER: PFNX)


Pfenex Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PFNX Gross Profit Margin (Jun 30 2020)
Q2 		(Mar 31 2020)
Q1 		(Dec 31 2019)
Q4 		(Sep 30 2019)
Q3 		(Jun 30 2019)
Q2
Y / Y Revenue Change -72.22 %
Seq. Revenue Change 14.52 %
Revenue In Millions $0.78
Gross Profit Margin 12.93 %
Gross Profit Margin Total Ranking # 3448
Gross Profit In Millions $0.10
Y / Y Gross Profit Change -94.02 %
Seq. Gross Profit Change -70.47 %


Commenting Second Quarter 2020 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 12.93 % due to increase in Cost of Sales and despite Revenue increase of 14.52 % to $1 millions.
Pfenex Inc achieved highest Gross Profit Margin in II. Quarter


Observing second quarter 2020 results within Major Pharmaceutical Preparations industry 157 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1593 to 3448.
Learn about Gross Margin
PFNX's Gross Profit Margin second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 465
Overall # 3359

Gross Profit Margin Statistics
High Average Low
97.37 % 62.02 % 12.93 %
(Sep 30 2016)   (Jun 30 2020)


PFNX Gross Income Trends • More of PFNX's Profitabilty Ratios • PFNX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PFNX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PFNX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PFNX's Competitors
Gross Profit Margin Profit Margin for Pfenex Inc 's Suppliers
Gross Profit Margin Profit Margin for PFNX's Customers

You may also want to know
PFNX's Annual Growth Rates PFNX's Profitability Ratios PFNX's Asset Turnover Ratio PFNX's Dividend Growth
PFNX's Roe PFNX's Valuation Ratios PFNX's Financial Strength Ratios PFNX's Gross Profit Growth
PFNX's Roa PFNX's Inventory Turnover Ratio PFNX's Growth Rates PFNX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2020, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2020 MRQ Gross ProfitJun 30 2020 MRQ Revenue
Prophase Labs Inc   35.30 %$ 1.279  Millions$ 3.623  Millions
Avid Bioservices Inc   33.65 %$ 8.544  Millions$ 25.392  Millions
Earth Science Tech Inc   33.23 %$ 0.024  Millions$ 0.072  Millions
American Bio Medica Corporation  33.11 %$ 0.582  Millions$ 1.758  Millions
Phibro Animal Health Corporation  32.58 %$ 60.564  Millions$ 185.883  Millions
Aclaris Therapeutics Inc   32.11 %$ 0.657  Millions$ 2.046  Millions
Amneal Pharmaceuticals Inc   31.09 %$ 144.237  Millions$ 463.903  Millions
China Pharma Holdings Inc  30.49 %$ 1.150  Millions$ 3.771  Millions
Scienture Holdings Inc   30.41 %$ 2.005  Millions$ 6.593  Millions
Vireo Growth Inc.  29.39 %$ 3.591  Millions$ 12.215  Millions
Musclepharm Corporation  29.33 %$ 4.984  Millions$ 16.993  Millions
Soligenix inc   28.09 %$ 0.142  Millions$ 0.505  Millions
Akorn Inc  25.81 %$ 31.052  Millions$ 120.310  Millions
Societal Cdmo Inc   25.05 %$ 3.888  Millions$ 15.522  Millions
Nabriva Therapeutics Plc  24.44 %$ 0.119  Millions$ 0.487  Millions
Enveric Biosciences Inc   22.02 %$ 1.818  Millions$ 8.255  Millions
Lftd Partners Inc   19.71 %$ 0.250  Millions$ 1.268  Millions
Ernexa Therapeutics Inc   18.70 %$ 0.141  Millions$ 0.754  Millions
Teligent Inc   18.42 %$ 2.502  Millions$ 13.586  Millions
Athenex Inc   17.84 %$ 7.166  Millions$ 40.172  Millions
Xbiotech Inc   14.82 %$ 2.297  Millions$ 15.498  Millions
Generex Biotechnology Corp  14.59 %$ 0.419  Millions$ 2.874  Millions
Pfenex Inc   12.93 %$ 0.101  Millions$ 0.781  Millions
Longeveron Inc   12.79 %$ 0.112  Millions$ 0.876  Millions
Catalent Inc   10.81 %$ 334.600  Millions$ 3,094.000  Millions
Integrated Biopharma Inc  10.71 %$ 1.450  Millions$ 13.535  Millions
Igc Pharma Inc   7.88 %$ 0.046  Millions$ 0.584  Millions
Rockwell Medical inc   5.54 %$ 0.881  Millions$ 15.896  Millions
Bioadaptives Inc   4.20 %$ 0.000  Millions$ 0.004  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.